WHO launches '3 by 35' initiative to tackle chronic diseases
The initiative comes as a direct response to the rising global burden of noncommunicable diseases (NCDs), such as heart disease, cancer, and diabetes, which now account for over 75% of all deaths worldwide.
'Health taxes are one of the most efficient tools we have,' said Dr Jeremy Farrar, Assistant Director-General, Health Promotion and Disease Prevention and Control, WHO in a statement here. 'They cut the consumption of harmful products and create revenue governments can reinvest in health care, education, and social protection. It's time to act.'
Blatant spike in NCDs have placed an immense strain on global health systems, already grappling with reduced development aid and growing public debt.
The call for higher taxes on these harmful products is expected to curb consumption, particularly among vulnerable populations, and simultaneously generate much-needed public revenue for health infrastructure and prevention programs, added the statement.
Recent studies highlight the potential of such measures, with projections suggesting that a one-time 50% price hike on tobacco, alcohol, and sugary drinks could prevent as many as 50 million premature deaths over the next five decades.
The initiative has an ambitious but achievable goal of raising USD1 trillion over the next 10 years. Between 2012 and 2022, nearly 140 countries raised tobacco taxes, which resulted in an increase of real prices by over 50% on average, showing that large-scale change is possible.
From Colombia to South Africa, governments that have introduced health taxes have seen reduced consumption and increased revenue. Yet many countries continue to provide tax incentives to unhealthy industries, including tobacco, as per the statement.
Moreover, long-term investment agreements with industry that restrict tobacco tax increases can further undermine national health goals. 'The WHO encourages governments to review and avoid such exemptions to support effective tobacco control and protect public health,' said the statement.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
2 hours ago
- Indian Express
Vaccine manufacturers' body, Serum Institute of India reaffirm COVID-19 vaccine safety
The Indian Vaccine Manufacturers Association (IVMA) has assured that all COVID-19 vaccines in India were approved for emergency use authorisation based on extensive evaluation in preclinical studies and human clinical trials. 'Patient safety and product quality are always prioritised during the vaccine development and its manufacture,' Dr G V J A Harshavardhan, Director General, IVMA, said in a statement released on Thursday. The statement sought to reassure the public on the safety and efficacy of COVID-19 vaccines. 'All COVID-19 vaccines in India were approved for emergency use authorisation [restricted use in emergency situations as per World Health Organization guidelines], he said, adding, 'These approvals were based on extensive evaluation in preclinical studies and human clinical trials, with positive results on safety, efficacy, and immunogenicity of these vaccines.' The IVMA statement comes in the backdrop of the Union health ministry saying on Wednesday that extensive studies by several agencies have 'conclusively established no linkages' between COVID-19 vaccines and sudden deaths. The Serum Institute of India also posted on X that the COVID-19 vaccines were safe and scientifically validated. 'Two large-scale studies by ICMR [Indian Council of Medical Research] and AIIMS [All India Institute of Medical Sciences], as cited by the Ministry of Health have found no link between Covid-19 vaccines and sudden deaths,' SII said. The IVMA statement also noted that prior to their release, all COVID-19 vaccines were tested extensively for safety by the manufacturers and were also provided Batch Release Certification by the Central Drugs Laboratory in Kasauli, Himachal Pradesh, under the Ministry of Health and Family Welfare. 'The strengths of innovation and large-scale, high-quality manufacturing are the hallmarks of the Indian vaccine ecosystem. COVID-19 vaccines manufactured in India were largely responsible for not only controlling the COVID-19 pandemic and restricting its impact on lives, livelihoods, but most importantly, enabling India's economic activity and GDP to rebound and grow to new heights globally,' Dr Harshavardhan said. 'This positive impact of COVID-19 vaccination was not only limited to India, but also to several countries worldwide, under the Government of India's Vaccine Maitri programme…,' he added.
United News of India
3 hours ago
- United News of India
Surge in pink eye conjunctivitis cases in Kerala
Thiruvananthapuram, July 4 (UNI) With the onset of torrential rains, a surge in cases of pink eye conjunctivitis, also known as eye flu, is raising alarm across Kerala. "This year, the infection is more viral than bacterial in nature and is assuming alarming proportions in Kerala. The infection is highly contagious and can spread rapidly from one individual to another," said Dr. Naresh Purohit, Advisor to the National Blindness Control Programme. Pink eye conjunctivitis occurs due to inflammation of the conjunctiva, the thin membrane that covers the white part of the eye, he explained. It is a painful ocular condition. The prevailing high humidity during the rainy season fosters viral growth, creating favorable conditions for the spread of conjunctivitis, Epidemiologist Dr. Purohit said. "Areas with frequent waterlogging and regions where hygiene practices are poor, such as slum dwellings, are at higher risk of transmission. Currently, in the urban areas of the state, children, their family members, and even healthcare workers have been significantly impacted, accounting for almost 30-40% of the affected group,' said Dr. Purohit, who is also the Principal Investigator for the National Integrated Disease Surveillance Programme (NIDSP). The symptoms of conjunctivitis include redness in one or both eyes, increased itching, eye discharge, and sensitivity to light (photophobia). "Viruses and bacteria, allergies, close contact with harmful chemicals, a blocked tear duct, and exposure to allergens such as pollen and dust mites are among the most common causes of conjunctivitis," he added. "Maintaining good hygiene is essential for preventing the disease. Basic practices such as regularly washing the face, avoiding touching the eyes frequently, keeping surroundings clean, and observing rigorous personal hygiene are effective ways to stay protected from eye flu," he emphasized. UNI DS RKM
News18
3 hours ago
- News18
Brain-Eating Amoeba In Pools And Tanks? What You Should Know This Monsoon
Last Updated: Naegleria fowleri is a free‑living amoeba that thrives in ponds, lakes, slow‑moving rivers, poorly chlorinated swimming pools, and even domestic water storage. Find out more When the monsoon lashes India each year, it leaves behind more than swollen rivers and traffic snarls. Warm, rain‑fed pools and half‑chlorinated overhead tanks become breeding grounds for Naegleria fowleri—the so‑called 'brain‑eating amoeba". The microscopic organism causes primary amoebic meningoencephalitis (PAM), a disease so rare that most doctors never see a case—but so lethal it kills over 95%of those infected. With July 2025 rainfall already above normal in some states, public‑health officials are warning residents to stay vigilant around warm fresh water. Let's understand Naegleria fowleri's ecology, how it shows up in India, and – most importantly – how to stay safe. What Exactly Is Naegleria fowleri? Naegleria fowleri is a free‑living amoeba that thrives in warm fresh water—ponds, lakes, slow‑moving rivers, thermal springs, poorly chlorinated swimming pools, and even domestic water storage. It has three life stages: • Cyst (dormant, resilient to cold) • Trophozoite (feeding form, infectious) • Flagellate (motile form that seeks new environments) Human infection occurs when contaminated water is forced up the nose, typically during swimming, ritual ablution, or vigorous douching. The amoeba travels along the olfactory nerve, crosses the cribriform plate, and attacks brain tissue. Warmer Water Temperatures As per the India Meteorological Data (IMD), average surface temperatures in ponds and reservoirs across the Gangetic plain now hover around 32-34 °C during July—prime conditions for Naegleria fowleri. Urban Water‑Storage Habits Many Indian households store water in rooftop tanks or underground sumps that are rarely cleaned. A 2024 National Centre for Disease Control (NCDC) survey in Delhi and Jaipur found 42% of domestic tanks had free‑chlorine levels below WHO's recommended 0.5 mg/L, creating a safe haven for the amoeba. In Kerala 2023, an 11‑year‑old girl from Alappuzha died after swimming in a canal; lab tests confirmed Naegleria. Last year in Ahmedabad, municipal workers detected the amoeba in an apartment‑complex pool during routine checks; no fatalities, but the episode triggered fresh chlorination rules. In May in Mumbai, a 17‑year‑old boy succumbed at a suburban hospital after using a gym spa pool that tested positive for Naegleria. Although fewer than 20 Indian cases have been confirmed since records began, under‑reporting is likely because PAM symptoms resemble common viral meningitis and diagnostic PCR tests are limited to NIV Pune and a handful of state labs. How Does India Monitor Naegleria? Integrated Disease Surveillance Programme (IDSP): PAM is a notifiable disease since 2022; district hospitals must report suspected cases within 24 hours. Routine Water Sampling: Municipal corporations in major metros now test public pools monthly for free‑chlorine residuals and thermophilic amoebae. Hospital Alerts: NCDC has issued standard operating procedures for early lumbar‑puncture and CSF PCR testing when meningitis does not respond to antibiotics within 24 hours. What's The Treatment? The US Center for Disease Control and Prevention (CDC) recommends an aggressive cocktail of intravenous amphotericin B, rifampicin, fluconazole, azithromycin, and miltefosine, plus targeted hypothermia to reduce brain swelling. India's Directorate General of Health Services (DGHS) imported miltefosine in 2016 after the first Kerala case and stocks it through central medical stores. Still, treatment success worldwide is limited; of more than 430 documented cases, only about 20 survivors exist. Precautions You Should Take Avoid forceful water entry into nose: Don't dive or dunk in warm/standing fresh water. While bathing infants, avoid splashing water up their nostrils. Use chlorinated water for nasal rinses: For neti‑pot or jal‑neti practice, boil water (rolling boil 1 minute) and cool or use distilled/RO water. Maintain domestic tanks & pools: Clean storage tanks every three months; keep free chlorine ≥ 0.5 mg/L. Apartment associations should test pool water weekly in July–September. Public pool etiquette: Check if pool management displays daily chlorine readings. Avoid swimming if water is cloudy or the deck smells musty. Seek immediate care for Meningitis‑like symptoms: If severe headache and fever follow recent swimming, insist on Cerebrospinal Fluid (CSF) testing and mention Naegleria to your doctor. Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! tags : brain-eating amoeba India monsoon Location : New Delhi, India, India First Published: July 03, 2025, 17:05 IST News india Brain-Eating Amoeba In Pools And Tanks? What You Should Know This Monsoon
